Antimicrobial Susceptibility Survey of Streptococcus pyogenes Isolated in Japan from Patients with Severe Invasive Group A Streptococcal Infections-Reference-Cited by-同舟云学术

Antimicrobial Susceptibility Survey of Streptococcus pyogenes Isolated in Japan from Patients with Severe Invasive Group A Streptococcal Infections

Published:2005-02 Issue:2 Volume:49 Page:788-790
ISSN:0066-4804
Container-title:Antimicrobial Agents and Chemotherapy
language:en
Short-container-title:Antimicrob Agents Chemother

Author:

Ikebe Tadayoshi¹,Hirasawa Kyoko²,Suzuki Rieko³,Isobe Junko⁴,Tanaka Daisuke⁴,Katsukawa Chihiro⁵,Kawahara Ryuji⁵,Tomita Masaaki⁶,Ogata Kikuyo⁷,Endoh Miyoko⁸,Okuno Rumi⁸,Watanabe Haruo¹

Affiliation:

1. Department of Bacteriology, National Institute of Infectious Diseases

2. Department of Bacteriology, Fukushima Prefectural Institute of Public Health, Fukushima

3. Department of Microbiology, Kanagawa Prefectural Public Health Laboratory, Kanagawa

4. Department of Bacteriology, Toyama Institute of Health, Toyama

5. Department of Infectious Diseases, Osaka Prefectural Institute of Public Health, Osaka

6. Division of Biological Medicine, Yamaguchi Prefectural Research Institute of Public Health, Yamaguchi

7. Department of Bacteriology, The Oita Prefectural Institute of Health and Environment, Oita, Japan

8. Department of Bacteriology, Tokyo Metropolitan Institute of Public Health, Tokyo

Abstract

ABSTRACT We assessed antimicrobial susceptibility against 211 Streptococcus pyogenes strains isolated from patients with severe invasive group A streptococcal infections. Overall, 3.8, 1.4, 1.4, and 0.5% of the isolates were resistant to erythromycin, clindamycin, telithromycin, and ciprofloxacin, respectively, and 10.4% had intermediate resistance to ciprofloxacin. All isolates were susceptible to ampicillin and cefotaxime.

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Link

https://journals.asm.org/doi/pdf/10.1128/AAC.49.2.788-790.2005

Reference11 articles.

1. Arvand, M., M. Hoeck, H. Hahn, and J. Wagner. 2000. Antimicrobial resistance in Streptococcus pyogenes isolates in Berlin. J. Antimicrob. Chemother.46:621-624.

2. Prevalence and Mechanisms of Macrolide Resistance in Clinical Isolates of Group A Streptococci from Ontario, Canada

3. Felmingham, D., J. D. Farrell, R. R. Reinert, and I. Morrissey. 2004. Antibacterial resistance among children with community-acquired respiratory tract infections (PROTEKT 1999-2000). J. Infect.48:39-55.

4. Dissemination of the Phage-Associated Novel Superantigen Gene speL in Recent Invasive and Noninvasive Streptococcus pyogenes M3/T3 Isolates in Japan

5. Ikebe, T., N. Murai, M. Endo, R. Okuno, S. Murayama, K. Saitoh, S. Yamai, R. Suzuki, J. Isobe, D. Tanaka, C. Katsukawa, A. Tamaru, A. Katayama, Y. Fujinaga, K. Hoashi, J. Ishikawa, H. Watanabe, and the Working Group for Group A Streptococci in Japan. 2003. Changing prevalent T serotypes and emm genotypes of Streptococcus pyogenes isolates from streptococcal toxic shock-like syndrome (TSLS) patients in Japan. Epidemiol. Infect.130:569-572.

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diagnostic clue for cutaneous characteristics of streptococcus pyogenes infection after COVID-19 epidemic in pediatrics in Beijing;2024-08-28

2. Dihydrothiazolo ring-fused 2-pyridone antimicrobial compounds treat Streptococcus pyogenes skin and soft tissue infection;Science Advances;2024-08-02

3. Dihydrothiazolo ring-fused 2-pyridone antimicrobial compounds treatStreptococcus pyogenesskin and soft tissue infection;2024-01-03

4. The increasing incidence of invasive infections caused by Streptococcus pyogenes in Europe;Medic.ro;2023

5. Prevalence and antibiotic susceptibility of Streptococcus pyogenes isolated from pyoderma in a tertiary care hospital, Hyderabad, South India;Indian Journal of Microbiology Research;2021-12-15